Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

PEPG | PepGen Inc

IndexRUT P/E- EPS (ttm)-2.93 Insider Own23.02% Shs Outstand23.71M Perf Week-1.69%
Market Cap124.76M Forward P/E- EPS next Y-3.42 Insider Trans-0.57% Shs Float18.33M Perf Month-2.33%
Income-69.38M PEG- EPS next Q-0.88 Inst Own74.33% Short Float / Ratio1.16% / 4.22 Perf Quarter-45.07%
Sales0.00M P/S- EPS this Y24.43% Inst Trans-0.55% Short Interest0.21M Perf Half Y-65.59%
Book/sh6.18 P/B0.85 EPS next Y-2.40% ROA-33.61% Target Price23.20 Perf Year6.29%
Cash/sh6.18 P/C0.85 EPS next 5Y- ROE-38.82% 52W Range4.32 - 20.00 Perf YTD-60.81%
Dividend- P/FCF- EPS past 5Y- ROI-42.01% 52W High-73.80% Beta1.12
Dividend %- Quick Ratio8.88 Sales past 5Y0.00% Gross Margin- 52W Low21.30% ATR0.52
Employees45 Current Ratio8.88 Sales Q/Q- Oper. Margin0.00% RSI (14)39.93 Volatility9.86% 8.72%
OptionableNo Debt/Eq0.15 EPS Q/Q33.22% Profit Margin- Rel Volume0.12 Prev Close5.12
ShortableYes LT Debt/Eq0.12 EarningsAug 08 BMO Payout- Avg Volume50.40K Price5.24
Recom1.00 SMA20-11.30% SMA50-15.21% SMA200-56.57% Volume3,543 Change2.34%
Date Action Analyst Rating Change Price Target Change
Dec-21-22Initiated H.C. Wainwright Buy $26
Sep-06-23 04:05PM
08:00AM
Sep-01-23 08:00AM
Aug-08-23 08:15AM
Jun-13-23 04:05PM
11:44AM Loading…
May-31-23 11:44AM
May-30-23 04:05PM
May-18-23 07:00AM
May-11-23 07:00AM
May-04-23 08:00AM
Apr-17-23 08:00AM
Apr-13-23 04:05PM
Mar-27-23 02:25AM
Mar-23-23 04:05PM
Mar-22-23 08:00AM
04:05PM Loading…
Mar-21-23 04:05PM
Mar-16-23 08:00AM
Mar-13-23 08:00AM
Feb-27-23 08:50AM
Feb-09-23 08:00AM
Jan-31-23 08:50AM
Jan-16-23 05:10AM
Jan-13-23 08:50AM
Dec-21-22 02:25PM
Dec-07-22 08:00AM
Dec-01-22 09:55AM
Nov-21-22 08:50AM
Nov-15-22 09:55AM
Nov-14-22 08:00AM
Nov-10-22 08:00AM
08:00AM Loading…
Nov-08-22 08:00AM
Oct-13-22 01:00PM
Sep-28-22 01:59PM
09:25AM
06:00AM
Sep-22-22 08:00AM
Sep-04-22 07:17AM
Aug-12-22 08:00AM
Aug-08-22 10:51AM
Jul-22-22 07:45AM
Jun-16-22 08:30AM
May-27-22 05:22PM
May-05-22 11:34PM
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McArthur James GPresident and CEOJun 08Option Exercise2.712,3816,4532,381Jun 09 07:06 PM
McArthur James GPresident and CEOJun 08Sale16.042,38138,1880Jun 09 07:06 PM
McArthur James GPresident and CEOJun 07Option Exercise2.718,41922,8158,419Jun 08 05:23 PM
McArthur James GPresident and CEOJun 07Sale16.238,419136,6180Jun 08 05:23 PM
McArthur James GPresident and CEOJun 06Option Exercise2.7118,15049,18618,150Jun 08 05:23 PM
McArthur James GPresident and CEOJun 06Sale16.1818,150293,6600Jun 08 05:23 PM
McArthur James GPresident and CEOJun 05Option Exercise2.715001,355500Jun 06 04:19 PM
McArthur James GPresident and CEOJun 05Sale16.065008,0280Jun 06 04:19 PM
McArthur James GPresident and CEOJun 02Option Exercise2.711,8004,8781,800Jun 06 04:19 PM
McArthur James GPresident and CEOJun 02Sale16.041,80028,8630Jun 06 04:19 PM
Goyal JayaEVP, Res. & Preclin. Dev.Mar 24Option Exercise10.883924,265392Mar 28 07:36 PM
Goyal JayaEVP, Res. & Preclin. Dev.Mar 24Sale20.003927,8400Mar 28 07:36 PM
Goyal JayaEVP, Res. & Preclin. Dev.Feb 08Option Exercise10.886447,007644Feb 08 05:42 PM
Goyal JayaEVP, Res. & Preclin. Dev.Feb 08Sale17.0064410,9480Feb 08 05:42 PM
Goyal JayaEVP, Res. & Preclin. Dev.Feb 07Option Exercise10.883,67940,0283,679Feb 08 05:42 PM
Goyal JayaEVP, Res. & Preclin. Dev.Feb 07Sale17.183,67963,2130Feb 08 05:42 PM
Goyal JayaEVP, Res. & Preclin. Dev.Feb 06Option Exercise10.881,67718,2461,677Feb 08 05:42 PM
Goyal JayaEVP, Res. & Preclin. Dev.Feb 06Sale17.041,67728,5680Feb 08 05:42 PM
Svenstrup NielsSVP, Chem. Mfg & ControlsDec 19Option Exercise2.7110,00027,10010,000Dec 19 04:16 PM